ThermoGenesis Holdings Inc. [THMO] Stock trading around $0.21 per share: What’s Next?

ThermoGenesis Holdings Inc. [NASDAQ: THMO] stock went on a downward path that fall over -7.91% on Wednesday, amounting to a one-week price increase of more than 9.57%. The company report on September 7, 2022 that ThermoGenesis Holdings to Present at the H.C. Wainwright 24th Annual Global Investment Conference.

Top 5 Cheap Stocks to Own Right Now

While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.

Sign up here to get your free report now. .


ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today announced that Chris Xu, Ph.D., Chief Executive Officer, will present a company overview at the H.C. Wainwright 24th Annual Global Investment Conference, taking place September 12-14, 2022.  Details of Dr. Xu’s in-person presentation are as follows:.

Over the last 12 months, THMO stock dropped by -90.88%. The one-year ThermoGenesis Holdings Inc. stock forecast points to a potential upside of 79.0.

The market cap for the stock reached $6.47 million, with 31.32 million shares outstanding and 19.04 million shares in the current float. Compared to the average trading volume of 3.02M shares, THMO stock reached a trading volume of 15356898 in the most recent trading day, which is why market watchdogs consider the stock to be active.

Guru’s Opinion on ThermoGenesis Holdings Inc. [THMO]:

H.C. Wainwright have made an estimate for ThermoGenesis Holdings Inc. shares, keeping their opinion on the stock as Buy, with their previous recommendation back on May 23, 2018. The new note on the price target was released on December 22, 2015, representing the official price target for ThermoGenesis Holdings Inc. stock. Previously, the target price had yet another drop from $7 to $1, while Maxim Group kept a Buy rating on THMO stock.

The Average True Range (ATR) for ThermoGenesis Holdings Inc. is set at 0.04, with the Price to Sales ratio for THMO stock in the period of the last 12 months amounting to 0.57. The Price to Book ratio for the last quarter was 0.46, with the Price to Cash per share for the same quarter was set at 0.13.

THMO Stock Performance Analysis:

ThermoGenesis Holdings Inc. [THMO] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 9.57. With this latest performance, THMO shares dropped by -19.31% in over the last four-week period, additionally sinking by -62.87% over the last 6 months – not to mention a drop of -90.88% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for THMO stock in for the last two-week period is set at 45.41, with the RSI for the last a single of trading hit 44.96, and the three-weeks RSI is set at 45.13 for ThermoGenesis Holdings Inc. [THMO]. The present Moving Average for the last 50 days of trading for this stock 0.2245, while it was recorded at 0.2149 for the last single week of trading, and 0.5790 for the last 200 days.

Insight into ThermoGenesis Holdings Inc. Fundamentals:

Operating Margin for any stock indicates how profitable investing would be, and ThermoGenesis Holdings Inc. [THMO] shares currently have an operating margin of -77.80 and a Gross Margin at +32.97. ThermoGenesis Holdings Inc.’s Net Margin is presently recorded at -122.43.

Return on Equity for this stock declined to -236.37, with Return on Assets sitting at -54.82.

ThermoGenesis Holdings Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.70 and a Current Ratio set at 1.20.

ThermoGenesis Holdings Inc. [THMO] Insider Position Details

There are presently around $0 million, or 2.30% of THMO stock, in the hands of institutional investors. The top three institutional holders of THMO stocks are: CITADEL ADVISORS LLC with ownership of 195,192, which is approximately New of the company’s market cap and around 5.52% of the total institutional ownership; VIRTU FINANCIAL LLC, holding 189,671 shares of the stock with an approximate value of $40000.0 in THMO stocks shares; and VANGUARD GROUP INC, currently with $18000.0 in THMO stock with ownership of nearly 0% of the company’s market capitalization.

Positions in ThermoGenesis Holdings Inc. stocks held by institutional investors increased at the end of August and at the time of the August reporting period, where 8 institutional holders increased their position in ThermoGenesis Holdings Inc. [NASDAQ:THMO] by around 491,701 shares. Additionally, 4 investors decreased positions by around 45,226 shares, while 10 investors held positions by with 187,194 shares. The mentioned changes placed institutional holdings at 724,121 shares, according to the latest SEC report filing. THMO stock had 6 new institutional investments in for a total of 491,052 shares, while 2 institutional investors sold positions of 43,024 shares during the same period.


Please enter your comment!
Please enter your name here